M W Fanger - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

M W Fanger

Showing results (101-110 of 102) with videos related to

Pageof 11

Sort By:

You have reached the last page of results.This site can display upto 102 results.

Journal of Immunological Methods|February 27, 2001

Bispecific antibody-targeted phagocytosis of HER-2/neu expressing tumor cells by myeloid cells activated in vivoP K Wallace, P A Kaufman, L D Lewis, et al.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2001

Phase I pilot trial of the bispecific antibody MDXH210 (anti-Fc gamma RI X anti-HER-2/neu) in patients whose prostate cancer overexpresses HER-2/neuT Schwaab, L D Lewis, B F Cole, et al.

Pageof 11

Search research articles

Showing results (101-110 of 102) with videos related to

Sort By:

Pageof 11

You have reached the last page of results.This site can display upto 102 results.

Journal of Immunological Methods|February 27, 2001

Bispecific antibody-targeted phagocytosis of HER-2/neu expressing tumor cells by myeloid cells activated in vivoP K Wallace, P A Kaufman, L D Lewis, et al.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2001

Phase I pilot trial of the bispecific antibody MDXH210 (anti-Fc gamma RI X anti-HER-2/neu) in patients whose prostate cancer overexpresses HER-2/neuT Schwaab, L D Lewis, B F Cole, et al.

Pageof 11